Zecita Plus 10 Tablet contains a combination of Clonazepam (0.5 mg) and Escitalopram Oxalate (10 mg), formulated for the management of anxiety disorders, panic attacks, and depression. Clonazepam, a benzodiazepine, exerts its therapeutic effect by enhancing the activity of gamma-aminobutyric acid (GABA) in the central nervous system, producing anxiolytic, anticonvulsant, and muscle relaxant properties. Escitalopram Oxalate, a selective serotonin reuptake inhibitor (SSRI), increases serotonin levels in the brain, thereby improving mood and reducing symptoms of depression and anxiety. The combination of these agents provides a synergistic effect, offering rapid relief from acute anxiety symptoms while addressing underlying depressive disorders. Zecita Plus 10 is indicated for patients requiring both immediate anxiolytic action and long-term antidepressant therapy. It should be used under strict medical supervision, with dosage adjustments tailored to individual patient response and tolerability. Common side effects may include drowsiness, dizziness, dry mouth, gastrointestinal disturbances, and potential withdrawal symptoms upon abrupt discontinuation. Caution is advised in patients with a history of substance abuse, liver or kidney impairment, and during pregnancy or lactation. Regular monitoring is recommended to assess therapeutic efficacy and detect adverse effects promptly.